Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice

Authors:

Abstract
We previously reported that the apolipoprotein (apo) B48-carrying lipoproteins obtained from apoE knockout (apoE−/−) mice, so called E−/B48 lipoproteins, transformed mouse macrophages into foam cells and enhanced the phosphorylation of eukaryotic translation initiation factor 2α(eIF-2α). Furthermore, the eIF-2αphosphorylation inhibitor, 2-aminopurine (2-AP), attenuated E−/B48 lipoprotein-induced foam cell formation. The present report studied the effect of 2-AP on atherosclerosis inapoE−/−mice. Our results showed that the level of food intake, bodyweight, plasma cholesterol, and triglycerides was comparable inapoE−/−mice treated with or without 2-AP. However, the mean size of atherosclerotic lesions in the aorta sinus as well as the surface area of the entire aorta of 2-AP-treatedapoE−/−mice were reduced by about 55% and 39%, respectively, compared to samples from untreated controlapoE−/−mice. In addition, the 2-AP-treatedapoE−/−mice showed a significant decrease in glucose-regulated protein 78 (GRP78) and phosphorylated eIF-2αin their aortic samples as compared to levels in untreated controlapoE−/−mice. These observations suggest that endoplasmic reticulum stress is a causal mechanism for the development of atherosclerosis inapoE−/−mice and that therapeutic strategies can be developed for using eIF-2αphosphorylation inhibitors, such as 2-AP, to prevent or treat atherosclerosis.
Funding Information
  • National Institutes of Health (SC1HL101431, U54RR026140, R01HL089382)
  • National Institutes of Health (SC1HL101431, U54RR026140, R01HL089382)
  • National Institutes of Health (SC1HL101431, U54RR026140, R01HL089382)

This publication has 26 references indexed in Scilit: